FDA NDC Directory · JSON-LD · Markdown

temozolomide

NDC 75834-142 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerNivagen Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA213328
Dosage form / routeCAPSULE · ORAL
Active ingredientsTEMOZOLOMIDE (20 mg/1)
Marketing started20211207
Package count2

External sources

Source: openFDA. Public-domain (CC0).